Studii clinice care confirma calitatile acestui produs

1) Bertilli, A. , Ronca, G. Carnitine and Coenzyme Q: Biochemical Properties and Functions, Synergism and Complementary Action. Int. Jour. Tiss. Reac., 12 (3): 183-186, 1990.

2) Bliznakov, Emile G., Coenzyme Q, the Immune System and Aging. Biomedical and Clinical Aspects of Coenzyme Q, 3: 311-323, 1981.

3) Conte, A. et. al., Protection of Adenylate Pool and Energy Charge by L-Carnitine and Coenzyme Q during Energy Depletion in Rat Heart Slices. Int. J.Tissue Reac.,12(3): 187-191, 1990.

4) Folkers, Karl et. al., Activities of Vitamin Q10 in Animal Models and a Serious Deficiency in Patients with Cancer. Biochem. Biophys. Res. Comm., 234(2): 296-299, 1997.

5) Folkers, Karl, Relationships between Coenzyme Q and Vitamin E. AJCN, 27: 1026-1034, 1974.

6) Folkers, Karl et. al., A One Year Bioavailability Study of Coenzyme Q10 with 3 Months Withdrawal Period. Molec. Aspects Med., 15: S281-S285, 1994.

7) Folkers, Karl et. al., Biochemical Deficiencies of Coenzyme Q10 in HIV-Infection and Exploratory Treatment. Austin, Texas, 1988.

8) Folkers, Karl, Relevance of the Biosynthesis of Coenzyme Q10 and of the Four Bases of DNA as a Rationale for the Molecular Causes of Cancer and a Therapy. Biochem. Biophys. Res. Comm., 224: 358-361, 1996.

9) Folkers, Karl and Simonsen, Rodney, Two Successful Double-blind Trials with Coenzyme Q10 (Vitamin Q10) on Muscular Dystrophies and Neurogenic Atrophies. Biochimica et Biophysica Acta, 1271: 281-286, 1995.

10) Folkers, K., and Langsjoen, Per H. et. al., Pronounced Increase of Survival of Patients with Cardiomyopathy when Treated with Coenzyme Q10 and Conventional Therapy. Int. J. Tiss. Reac., 12(3):163-168, 1990.

11) Hogenauer, G. et. al., The Macrophage Activating Potential of Ubiquinones. Biomedical and Clinical Aspects of Coenzyme Q, 3: 325-334, 1981.

12) Iwamoto, Y., Folkers, K., Deficiency of CoQ10 in Hypertensive Rats and Reduction of Deficiency by Treatment with Coenzyme Q10. Biochem. Biophys. Res. Comm. v58 n3: 743-748, 1974.

13) Judy, W.V. et. al., Regression of Prostate Cancer and Plasma Specific Antigens (PSA) in Patients on Treatment with CoQ10. International Coenzyme Q10 Association, Abstr. 143, 1998.

14) Judy, W.V. et. al., Dose Related Effectiveness of Coenzyme Q10 in the Treatment of Chronic Fatigue. Conference of the International Coenzyme Q10 Association, Abstr. 86, 1998.

15) Kaikkonen, Jari et. al., Effect of Oral Coenzyme Q10 Supplementation on the Oxidation and Resistance of Human VLDL+LDL Fraction: Absorption and Antioxidative Properties of Oil and Granule-Based Preparations. Free Radical Biology & Medicine, 22(7): 1195-1202, 1997.

16) Kamikawa, Tadashi et. al., Effects of Coenzyme Q10 on Exercise Tolerance in Chronic Stable Angina Pectoris. Am. J. Cardiol., 56(4): 247- 251, 1985.

17) Langsjoen, Per H. et. al., A Six-Year Clinical Study of Therapy of Cardiomyopathy with Coenzyme Q10. Int. J. Tiss. Reac., 12(3):169-171, 1990.

18) Manzoli, U. et. al., Coenzyme Q10 in Dilated Cardiomyopathy. Int. J. Tiss. Reac., 12(3): 173-178, 1990.

19) Morisco, C. et. al., Effect of Coenzyme Q10 Therapy in Patients with Congestive Heart Failure: A Long-term Multicenter Randomized Study. Clin. Invest., 71: S134-S136, 1993.

20) Poggesi, Loredana et. al., Effect of Coenzyme Q10 on Left Ventricular Function in Patients with Dilative Cardiomyopathy. Current Therapeutic Research, 49(5): 878-886, 1991.

21) Ronca, G., Conte A. et. al., Synergic and Complementary Effects of L-Carnitine and Coenzyme Q on Long-Chain Fatty Acid Metabolism and on Protection against Anthracycline Damage. Int. J. Tiss. Reac., 12(3):197-201, 1990.

22) Scaglione, F. et. al., Coenzyme Q10 as an Immunoenhancer. A Single Blind Placebo-Controlled and Randomized Clinical Study. Conference of the International Coenzyme Q10 Association, Abstr. 89, 1998.

23) Shults, Clifford W. et. al., Absorption, Tolerability, and Effect on Mitochondrial Activity of Oral Coenzyme Q10 in ParkinsonÕs Patients. Neurology, 50(3): 793-795, 1998.

24) Shults, Clifford W., Haas, Richard H. et. al., A Possible Role of CoEnzyme Q10 in the Etiology and Treatment of ParkinsonÕs Disease. Conference of the International Coenzyme Q10 Association, Abstr. 54, 1998.

25) Stocker, Roland et. al., Cosupplementation with Coenzyme Q Prevents the Prooxidant Effect of á-Tocopherol and Increases the Resistance of LDL to Transition Metal-Dependent Oxidation Initiation. Arteriosclerosis, Thrombosis, and Vascular Biology, 16(5): 687-696, 1996.

26) Stocker, Roland et. al., Ubiquinol-10 Protects Human Low Density Lipoprotein more Efficiently against Lipid Peroxidation than does á- Tocopherol. Proc. Natl. Acad. Sci., 88: 1646-1650, 1991.

27) Syburra, C.A. Oxidative Stress in Patients with Multiple Sclerosis. Conference of the International Coenzyme CoQ10 Association, Abstr. 125, 1998.

28) Wahlqvist, M.L. et. al., Bioavailability of Two Different Formulations of Coenzyme Q10 in Healthy Subjects. Asia Pacific J. Clin. Nutr., 7(1): 37-40, 1998.

29) Weber, Christine et. al., Intestinal Absorption of Coenzyme Q10 Administered in a Meal or as Capsules to Healthy Subjects. Nutrition Research, 17(6): 941-945, 1997.

30) Weis, M. et. al., Bioavailability of Four Oral Coenzyme Q10 Formulations in Healthy Volunteers. Molec. Aspects Med., 15: S273-S280, 1994.

31) Wilkinson, Edward G. et. al., Bioenergetics in Clinical Medicine II. Adjunctive Treatment with Coenzyme Q in Periodontal Therapy. Research Communications in Chemical Pathology and Pharmacology, 12(1): 111-124, 1975.

32) Williams, K.D., Manueke, J.D. et. al., 52-Week Oral Gavage Chronic Toxicity Study with Ubiquinone in Rats with a 4-Week Recovery. Conference of the International Coenzyme Q10 Association, Abstr. 73, 1998.

33) Shut, C.W., et. al., Effects of Coenzyme Q10 in Early Parkinson Disease. Arch of Neurology Vol. 59; 541-550, 2002.